Equities

Genetec Technology Bhd

GENETEC:KLS

Genetec Technology Bhd

Actions
IndustrialsIndustrial Engineering
  • Price (MYR)1.00
  • Today's Change0.055 / 5.82%
  • Shares traded51.48m
  • 1 Year change-57.98%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in MYRIncome statement in MYRView more

Year on year Genetec Technology Bhd grew revenues 31.77% from 223.56m to 294.59m while net income improved 18.14% from 56.40m to 66.63m.
Gross margin34.18%
Net profit margin24.24%
Operating margin26.18%
Return on assets11.95%
Return on equity15.21%
Return on investment14.26%
More ▼

Cash flow in MYRView more

In 2023, Genetec Technology Bhd did not generate a significant amount of cash. Cash Flow from Financing totalled 129.24m or 43.87% of revenues. In addition the company generated 92.35m in cash from operations while cash used for investing totalled 219.77m.
Cash flow per share0.0938
Price/Cash flow per share10.86
Book value per share0.6298
Tangible book value per share0.6233
More ▼

Balance sheet in MYRView more

Genetec Technology Bhd uses little debt in its capital structure as supported by a debt to capital ratio of 4.37%.
Current ratio6.80
Quick ratio6.57
Total debt/total equity0.0464
Total debt/total capital0.0437
More ▼

Growth rates in MYR

Year on year, growth in earnings per share excluding extraordinary items increased 16.57%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
Div yield(5 year avg)0.58%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)58.63
EPS (TTM) vs
TTM 1 year ago
-1.20
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.